China Universal Asset Management Co., Ltd. Horizon Therapeutics Public LTD CO Transaction History

China Universal Asset Management Co., Ltd.

$773 Million
Q1 2024

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 May 21, 2024	BUY	$98.98 - $115.74 $285,458 - $333,794	2,884 Added 96.26%	5,880 $680,000
Q3 2023 Oct 30, 2023	BUY	$98.98 - $115.74 $285,458 - $333,794	2,884 Added 96.26%	5,880 $680,000
Q2 2023 May 21, 2024	SELL	$96.34 - $112.38 $9,441 - $11,013	-98 Reduced 3.17%	2,996 $308,000
Q2 2023 Jul 27, 2023	SELL	$96.34 - $112.38 $9,441 - $11,013	-98 Reduced 3.17%	2,996 $308,000
Q1 2023 May 21, 2024	BUY	$107.32 - $113.5 $84,997 - $89,892	792 Added 34.4%	3,094 $337,000

Q1 2023 Apr 27, 2023	BUY	$107.32 - $113.5 $84,997 - $89,892	792 Added 34.4%	3,094 $338,000
Q4 2022 May 21, 2024	BUY	$62.39 - $113.8 $143,621 - $261,967	2,302 New	2,302 $261,000
Q4 2022 Jan 31, 2023	BUY	$62.39 - $113.8 $9,046 - $16,501	145 Added 6.72%	2,302 $262,000
Q3 2022 Oct 21, 2022	BUY	$58.92 - $84.67 $127,090 - $182,633	2,157 New	2,157 $133,000

Others Institutions Holding HZNP

# of Institutions

Shares Held

2.07M

Call Options Held

Put Options Held

20K

View Full List

About Horizon Therapeutics Public Ltd Co

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

More about HZNP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of China Universal Asset Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on China Universal Asset Management Co., Ltd. with notifications on news.

Account